Agarwal Arjun's Form 4 filing
Oruka Therapeutics, Inc. (ORKA) · filed Jun 15, 2026
- Accession no.
- 0000907654-26-000064
- Filed
- Jun 15, 2026
- Trade date
- Jun 12-15, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $687.0K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Agarwal ArjunCIK 0002033974 | Officer (Senior Vice President, Finance) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Common Stock | MOption exerciseAcquired | +8,000 | $12.50 | +$100,000 | 25,294 | Direct | |
| Jun 12, 2026 | Common Stock | MOption exerciseAcquired | +1,459 | $34.39 | +$50,175.01 | 26,753 | Direct | |
| Jun 12, 2026 | Common Stock | SSaleDisposed | −1,859 | $68.34 | −$127,044.06 | 24,894 | Direct | |
| Jun 12, 2026 | Common Stock | SSaleDisposed | −4,340 | $69.85 | −$303,149 | 20,554 | Direct | |
| Jun 12, 2026 | Common Stock | SSaleDisposed | −3,260 | $70.34 | −$229,308.4 | 17,294 | Direct | |
| Jun 15, 2026 | Common Stock | SSaleDisposed | −395 | $69.69 | −$27,527.55 | 16,899 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Common Stock | MOption exerciseDisposed | −8,000 | $0.00 | $0 | 110,000 | Direct | |
| Jun 12, 2026 | Common Stock | MOption exerciseDisposed | −1,459 | $0.00 | $0 | 62,708 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.